X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (13) 13
humans (13) 13
index medicus (13) 13
leukemia, lymphocytic, chronic, b-cell - genetics (12) 12
mutation (10) 10
survival (8) 8
oncology (7) 7
aged (6) 6
ataxia telangiectasia mutated proteins - genetics (6) 6
chronic lymphocytic leukemia (6) 6
clinical medicine (6) 6
female (6) 6
klinisk medicin (6) 6
male (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
middle aged (6) 6
adult (5) 5
leukemia, lymphocytic, chronic, b-cell - drug therapy (5) 5
prognosis (5) 5
tumor suppressor protein p53 - genetics (5) 5
ataxia telangiectasia mutated proteins - metabolism (4) 4
cancer (4) 4
cll (4) 4
fludarabine (4) 4
hematologi (4) 4
leukemia, lymphocytic, chronic, b-cell - metabolism (4) 4
leukemia, lymphocytic, chronic, b-cell - pathology (4) 4
tp53 mutation (4) 4
ataxia-telangiectasia (3) 3
atm (3) 3
cancer and oncology (3) 3
cancer och onkologi (3) 3
clonal evolution (3) 3
cohort studies (3) 3
dna-damage (3) 3
doxorubicin - pharmacology (3) 3
gene expression regulation, leukemic (3) 3
leukemia, lymphocytic, chronic, b-cell - diagnosis (3) 3
phosphoproteins - genetics (3) 3
receptor, notch1 - genetics (3) 3
ribonucleoprotein, u2 small nuclear - genetics (3) 3
rna splicing factors (3) 3
sf3b1 mutations (3) 3
tumor proteins (3) 3
tumor suppressor protein p53 - metabolism (3) 3
vidarabine - analogs & derivatives (3) 3
vidarabine - pharmacology (3) 3
11q deletion (2) 2
aged, 80 and over (2) 2
alleles (2) 2
analysis (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
ataxia telangiectasia mutated proteins - deficiency (2) 2
ataxia telangiectasia mutated proteins - physiology (2) 2
care and treatment (2) 2
chromosome deletion (2) 2
chronic lymphatic leukemia (2) 2
dna damage (2) 2
dna mutational analysis (2) 2
dysfunction (2) 2
evolution (2) 2
expression (2) 2
free survival (2) 2
gene deletion (2) 2
gene expression (2) 2
gene frequency (2) 2
gene mutations (2) 2
gene-mutations (2) 2
genes (2) 2
genes, p53 (2) 2
genetic aspects (2) 2
hematology, oncology and palliative medicine (2) 2
immunoglobulin heavy chains - genetics (2) 2
leukemia (2) 2
leukemia, lymphocytic, chronic, b-cell - classification (2) 2
leukemia, lymphocytic, chronic, b-cell - mortality (2) 2
lrf cll4 trial (2) 2
mutations (2) 2
myelodysplastic syndromes (2) 2
neoplasm proteins - genetics (2) 2
neoplasms (2) 2
notch1 (2) 2
p53 protein (2) 2
phosphorylation (2) 2
polymorphism, single nucleotide (2) 2
progression (2) 2
research (2) 2
retrospective studies (2) 2
sequence analysis, dna (2) 2
tp53 (2) 2
aberration (1) 1
aberrations (1) 1
activates atm (1) 1
activation (1) 1
advanced basic science (1) 1
alemtuzumab (1) 1
antibodies, monoclonal - pharmacology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 07/2017, Volume 31, Issue 7, pp. 1547 - 1554
Journal Article
Leukemia, ISSN 0887-6924, 02/2015, Volume 29, Issue 2, pp. 329 - 336
Journal Article
Leukemia, ISSN 0887-6924, 2015, Volume 29, Issue 5, pp. 1133 - 1142
Journal Article
Haematologica, ISSN 0390-6078, 01/2015, Volume 100, Issue 3, pp. 370 - 376
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 2016, Volume 101, Issue 9, pp. e369 - e373
Journal Article
Cell death & disease, ISSN 2041-4889, 2015, Volume 6, Issue 8, pp. e1852 - e1852
Journal Article
Experimental Hematology, ISSN 0301-472X, 2014, Volume 42, Issue 10, pp. 867 - 874.e1
Abnormalities in ATM and TP53 genes represent important predictive factors in chronic lymphocytic leukemia (CLL); however, the efficacy of CD20 targeting... 
Hematology, Oncology and Palliative Medicine | Advanced Basic Science | MEDICINE, RESEARCH & EXPERIMENTAL | CD20 EXPRESSION | COMPLEMENT-DEPENDENT CYTOTOXICITY | CHEMOIMMUNOTHERAPY | TP53 MUTATION | DYSFUNCTION | P53 TUMOR-SUPPRESSOR | MONOCLONAL-ANTIBODIES | HEMATOLOGY | ATAXIA-TELANGIECTASIA | FLUDARABINE | 11Q DELETION | CD59 Antigens - immunology | Humans | Middle Aged | Complement System Proteins - immunology | Drug Resistance, Neoplasm | Male | DNA Repair - genetics | Tumor Suppressor Protein p53 - physiology | Genes, p53 | Culture Media | Aged, 80 and over | Adult | Female | Serum | Tumor Cells, Cultured | CD55 Antigens - immunology | Neoplasm Proteins - genetics | Antigens, CD20 - immunology | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Rituximab | Tumor Suppressor Protein p53 - deficiency | Ataxia Telangiectasia Mutated Proteins - physiology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Aged | Ataxia Telangiectasia Mutated Proteins - deficiency | Antibodies, Monoclonal, Murine-Derived - pharmacology | Antigens, CD20 - drug effects | Ataxia Telangiectasia Mutated Proteins - genetics | Antigens, Neoplasm - drug effects | Drug Screening Assays, Antitumor | Antimitotic agents | Monoclonal antibodies | Chronic lymphocytic leukemia | Tumor proteins | Antineoplastic agents | Immunotherapy
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2011, Volume 11, pp. S145 - S146
Journal Article
Conference Proceeding